340B Drug Pricing Program
UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI NOVARTIS PHARMACEUTICALS CORPORATION, 鈥
AHA 340B Advocacy Alliance Bulletin for June 18, 2024
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide Medicare incentive payments to hospitals.
340B ADR process goes live June 18; informational webinar being held June 11The new 340B Administrative Dispute Resolution process, finalized by the Department of Health and Human Services April 18, goes into effect June 18. HRSA鈥檚 Office of Pharmacy Affairs June 11 will host a webinar to provide鈥
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent a letter to the subcommittee for the hearing, urging Congress to protect the program and highlighted its value to hospitals and health鈥
The House Energy and Commerce Oversight and Investigations subcommittee today hosted a hearing to discuss oversight of the 340B Drug Pricing Program.
AHA expresses strong support for the 340B program and urges Congress to protect this critical program as it has done for more than three decades.
AHA 340B Advocacy Alliance Bulletin for May 30, 2024.
The House Energy and Commerce Committee Subcommittee on Oversight and Investigations (O&I) June 4 will host a hearing titled, 鈥淥versight of 340B Drug Pricing Program.鈥 Please contact your Energy and Commerce member before the June 4 hearing and share with them the importance of the 340B program鈥
AHA 340B Advocacy Alliance Bulletin for May 21,2024.